Vitreoretinal Surgery Devices Market was valued at USD 1.68 billion in 2021 by DelveInsight

Global Vitreoretinal Surgery Devices Market was valued at USD 1.68 billion in 2021, growing at a CAGR of 7.69% during the forecast period from 2022 to 2027 to reach USD 2.62 billion by 2027.

The demand for Vitreoretinal Surgery Devices is primarily being boosted by the rising prevalence of eye diseases like retinal detachment, macular degeneration, diabetic retinopathy, and epiretinal membrane. Moreover, the rising geriatric population base, growing prevalence of lifestyle disorders such as diabetes, technical innovations in product development, and growing adaptability of less invasive procedures are expected to drive the vitreoretinal surgery product demand thereby contributing to the growth of the Vitreoretinal Surgery Devices market during the forecast period.

Key takeaways from the Vitreoretinal Surgery Devices Market Report
• According to DelveInsight analysis, North America is anticipated to dominate the global Vitreoretinal Surgery Devices market during the forecast period.
• In July 2021, Aldeyra Therapeutics, Inc. announced the US Food and Drug Administration (FDA) orphan drug designation for ADX-2191 (methotrexate for intravitreal injection) for the treatment of primary vitreoretinal lymphoma (PVRL).
• In June 2019, ZEISS India introduced FCI Vitreoretinal surgical devices in India. The FCI products were made available through an exclusive partnership between ZEISS India and FCI (France Chirurgie Instrumentation) S.A.S. This partnership offered the end-users a wide variety of options, which contributed to the growth of the Vitreoretinal Surgery Devices Market.
• In December 2019, BVI Medical acquired Arcadophtha SARL (Arcad), a France-based ophthalmic company specializing in silicone oils, gases, and perfluorocarbons used in vitreoretinal surgery. Growth in the Vitreoretinal Surgery Devices Market will be accelerated through the broad-reaching commercial infrastructure of BVI established with the Vitreq line of vitreoretinal surgical products.
• Vitreoretinal Surgery Devices Market Companies includes Bausch & Lomb Incorporated, Alcon Inc., Dutch Ophthalmic Research Center (International) B.V., OCULUS Optikgeräte GmbH, Paragon Care Group Australia Pty Ltd., MedOne Surgical, Inc., Zeiss Group, Geuder AG, Topcon Corporation, IRIDEX Corporation, Ellex Medical Lasers, Quantel Medical, MEDA Co., Ltd., Lumenis, NIDEK CO., LTD., Lightmed Corporation, Oertli Instrumente AG, BVI Medical, Johnson & Johnson Vision, OPTIKON, among others.

Download Sample Report- https://www.delveinsight.com/sample-request/vitreoretinal-surgery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Vitreoretinal Surgery Overview
Vitreoretinal surgery is done to treat the retina, macula, and vitreous fluid-associated eye diseases. These include macular degeneration, retinal detachment, vitreous hemorrhage and uveitis, macular void, epiretinal membrane, retinal detachment, and diabetic retinopathy-associated complications. These are different types of devices with varied applications during vitreoretinal surgery.

Vitreoretinal Surgery Market Dynamics
The Vitreoretinal Surgery Devices market is witnessing a growth in product demand owing to various reasons, one of the major reasons is the rising prevalence of vision impairment globally. These devices help in the improvement of visual fields of people suffering from Treatment and management of visual impairment. As per World Health Organization 2021, at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion - or almost half - of these cases, vision impairment could have been prevented or has yet to be addressed globally. As per the same source, the leading causes of vision impairment and blindness are uncorrected refractive errors and cataracts.

COVID19 Impact on the Vitreoretinal Surgery Market
Further, the outbreak of the COVID-19 pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospital procedures. This resulted in the reduced number of routine clinical examinations of the ophthalmic and related procedures. However, vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatient's visits, thereby bringing the demand for products on track in the Vitreoretinal Surgery Devices market. However, postoperative complications associated with Vitreoretinal Surgery Devices and retinal toxicity of medical devices used during Vitreoretinal Surgery may be certain impeding factors to Vitreoretinal Surgery Devices market growth.

Key Takeaways from the Vitreoretinal Surgery Devices Market Report Study
• Market size analysis for current Vitreoretinal Surgery Devices market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Vitreoretinal Surgery Devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the Global Vitreoretinal Surgery Devices Market.
• Various opportunities available for the other competitor in the Vitreoretinal Surgery Devices Market space.
• What are the top performing segments in 2021? How these segments will perform in 2027.
• Which is the top-performing regions and countries in the current Vitreoretinal Surgery Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Vitreoretinal Surgery Devices market growth in the coming future?

Scope of the Vitreoretinal Surgery Devices Market Report
• Coverage- Global
• Study Period- 2019-2027
• Vitreoretinal Surgery Devices Market By Type (Surgical Packs, Systems, Accessories, and Disposables),
• Vitreoretinal Surgery Devices Market By Product Type (Photocoagulation Surgery Devices, Vitrectomy Systems, Illumination Surgery Devices, Vitreoretinal Prefilled Silicone Oil Syringes, Others),
• Vitreoretinal Surgery Devices Market By End-User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centres),
• Vitreoretinal Surgery Devices Market By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
• Vitreoretinal Surgery Devices Market Companies- Bausch & Lomb Incorporated, Alcon Inc., Dutch Ophthalmic Research Center (International) B.V., OCULUS Optikgeräte GmbH, Paragon Care Group Australia Pty Ltd., MedOne Surgical, Inc., Zeiss Group, Geuder AG, Topcon Corporation, IRIDEX Corporation, Ellex Medical Lasers, Quantel Medical, MEDA Co., Ltd., Lumenis, NIDEK CO., LTD., Lightmed Corporation, Oertli Instrumente AG, BVI Medical, Johnson & Johnson Vision, OPTIKON, among others.

Request Sample Report- https://www.delveinsight.com/sample-request/vitreoretinal-surgery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of content
1. Vitreoretinal Surgery Devices Market Report Introduction
2. Vitreoretinal Surgery Devices Market Executive Summary
3. Regulatory and Patent Analysis
4. Vitreoretinal Surgery Devices Market Key Factors Analysis
5. Vitreoretinal Surgery Devices Market Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Vitreoretinal Surgery Devices Market
7. Vitreoretinal Surgery Devices Market Layout
8. Vitreoretinal Surgery Devices Market Global Company Share Analysis - Key 3-5 Companies
9. Vitreoretinal Surgery Devices Market Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us

Do you have any query related to the report? Visit here- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us
Yash
info@delveinsight.com

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.